Stevan G. Severtson

995 total citations
35 papers, 790 citations indexed

About

Stevan G. Severtson is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Emergency Medicine. According to data from OpenAlex, Stevan G. Severtson has authored 35 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 13 papers in Epidemiology and 9 papers in Emergency Medicine. Recurrent topics in Stevan G. Severtson's work include Opioid Use Disorder Treatment (18 papers), Poisoning and overdose treatments (9 papers) and Substance Abuse Treatment and Outcomes (9 papers). Stevan G. Severtson is often cited by papers focused on Opioid Use Disorder Treatment (18 papers), Poisoning and overdose treatments (9 papers) and Substance Abuse Treatment and Outcomes (9 papers). Stevan G. Severtson collaborates with scholars based in United States, Hong Kong and United Kingdom. Stevan G. Severtson's co-authors include Richard C. Dart, Jody L. Green, Nancy A. West, William W. Latimer, Becki Bucher‐Bartelson, Jonathan M. Davis, Steven P. Kurtz, Hilary L. Surratt, Lidush Goldschmidt and Gale A. Richardson and has published in prestigious journals such as PEDIATRICS, Journal of the American Academy of Dermatology and The Journal of Clinical Psychiatry.

In The Last Decade

Stevan G. Severtson

30 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stevan G. Severtson United States	15	489	239	220	168	139	35	790
Rachel Wightman United States	16	505 1.0×	221 0.9×	155 0.7×	101 0.6×	109 0.8×	48	828
Herschel Smith United States	6	757 1.5×	341 1.4×	219 1.0×	236 1.4×	110 0.8×	9	1.0k
Jody M. Cleveland United States	10	505 1.0×	228 1.0×	206 0.9×	187 1.1×	120 0.9×	17	748
S. Geoff Severtson United States	8	830 1.7×	277 1.2×	399 1.8×	293 1.7×	152 1.1×	17	1.1k
Zachary A. Kasper United States	12	621 1.3×	420 1.8×	164 0.7×	216 1.3×	104 0.7×	20	828
Christopher Rowe United States	19	713 1.5×	477 2.0×	223 1.0×	177 1.1×	66 0.5×	47	1.0k
R. Matt Gladden United States	10	602 1.2×	337 1.4×	135 0.6×	153 0.9×	90 0.6×	12	821
Jana McAninch United States	11	411 0.8×	156 0.7×	164 0.7×	156 0.9×	66 0.5×	17	636
Seonaid Nolan Canada	19	823 1.7×	720 3.0×	185 0.8×	201 1.2×	139 1.0×	67	1.3k
Stephanie D. Nichols United States	13	297 0.6×	151 0.6×	99 0.5×	143 0.9×	277 2.0×	36	680

Countries citing papers authored by Stevan G. Severtson

Since Specialization

Citations

This map shows the geographic impact of Stevan G. Severtson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stevan G. Severtson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stevan G. Severtson more than expected).

Fields of papers citing papers by Stevan G. Severtson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stevan G. Severtson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stevan G. Severtson. The network helps show where Stevan G. Severtson may publish in the future.

Co-authorship network of co-authors of Stevan G. Severtson

This figure shows the co-authorship network connecting the top 25 collaborators of Stevan G. Severtson. A scholar is included among the top collaborators of Stevan G. Severtson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stevan G. Severtson. Stevan G. Severtson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kale, Hrishikesh, Stevan G. Severtson, Becca Feldman, et al.. (2025). Clinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked database. BMC Psychiatry. 25(1). 727–727.

Marci, Carl D., Kruti Joshi, Stevan G. Severtson, Janis L. Breeze, & Manish K. Jha. (2025). Real-world evaluation of change in depressive symptoms among patients with treatment-resistant depression treated with esketamine. BMC Psychiatry. 25(1). 1195–1195.

Symons, James M., et al.. (2024). 53842 Real-World Dupilumab Continuation in US Children and Adolescents With Atopic Dermatitis Over a 24-Month Period. Journal of the American Academy of Dermatology. 91(3). AB294–AB294.

Marci, Carl D., Swapna Karkare, Manish K. Jha, Stevan G. Severtson, & Kruti Joshi. (2024). Change in Depressive Symptoms Following Esketamine Initiation among Patients with Treatment-Resistant Depression in a Real-World Setting. CNS Spectrums. 29(5). 518–518. 1 indexed citations

Severtson, Stevan G., et al.. (2023). Differences in Severity of Poison Centers Exposures Involving XTAMPZA ^® ER Versus Other Opioid Analgesics. Pain Management. 13(9). 519–527.

Buttram, Mance E., et al.. (2021). Increasing rates of buprenorphine diversion in the United States, 2002 to 2019. Pharmacoepidemiology and Drug Safety. 30(11). 1514–1519. 4 indexed citations

Murphy, David L., et al.. (2018). Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics. Drug Safety. 41(8). 787–795. 49 indexed citations

Butler, Stephen F., Ryan A. Black, Stevan G. Severtson, Richard C. Dart, & Jody L. Green. (2017). Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison Centers. Journal of Substance Abuse Treatment. 84. 42–49. 10 indexed citations

Vosburg, Suzanne K., Stevan G. Severtson, Richard C. Dart, et al.. (2017). Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System. Journal of Pain. 19(4). 439–453. 38 indexed citations

10.

Dart, Richard C., et al.. (2017). Increasing abuse of gabapentin and pregabalin as reported to U.S. poison centers 2006 through 2014. Drug and Alcohol Dependence. 171. e51–e51. 11 indexed citations

11.

Severtson, Stevan G., Matthew S. Ellis, Steven P. Kurtz, et al.. (2016). Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone. Drug and Alcohol Dependence. 168. 219–229. 46 indexed citations

12.

West, Nancy A., Stevan G. Severtson, Jody L. Green, & Richard C. Dart. (2015). Trends in abuse and misuse of prescription opioids among older adults. Drug and Alcohol Dependence. 149. 117–121. 128 indexed citations

13.

Lavonas, Eric J., Stevan G. Severtson, Erin Martinez, et al.. (2014). Abuse and diversion of buprenorphine sublingual tablets and film. Journal of Substance Abuse Treatment. 47(1). 27–34. 75 indexed citations

14.

Severtson, Stevan G., Becki Bucher Bartelson, Jonathan M. Davis, et al.. (2013). Reduced Abuse, Therapeutic Errors, and Diversion Following Reformulation of Extended-Release Oxycodone in 2010. Journal of Pain. 14(10). 1122–1130. 88 indexed citations

15.

Goldschmidt, Lidush, Gale A. Richardson, Jennifer A. Willford, Stevan G. Severtson, & Nancy L. Day. (2011). School achievement in 14-year-old youths prenatally exposed to marijuana. Neurotoxicology and Teratology. 34(1). 161–167. 78 indexed citations

16.

Severtson, Stevan G., et al.. (2011). Neighborhood & Family Effects on Learning Motivation among Urban African American Middle School Youth. Journal of Child and Family Studies. 21(1). 131–138. 21 indexed citations

17.

Severtson, Stevan G., et al.. (2010). The Relationship between Performance on the Shipley Institute of Living Scale (SILS) and Hepatitis C Infection among Active Injection Drug Users in Baltimore, Maryland. The American Journal of Drug and Alcohol Abuse. 36(1). 61–65. 4 indexed citations

18.

Severtson, Stevan G., et al.. (2010). The association between executive functioning and motivation to enter treatment among regular users of heroin and/or cocaine in Baltimore, MD. Addictive Behaviors. 35(7). 717–720. 24 indexed citations

19.

Severtson, Stevan G., et al.. (2009). The association between planning abilities and sharing injection drug use equipment among injection drug users in Baltimore, MD. Journal of Substance Use. 14(5). 325–333. 14 indexed citations

20.

Latimer, William W., et al.. (2009). Prevalence and Correlates of Hepatitis C among Injection Drug Users: The Significance of Duration of Use, Incarceration, and Race/Ethnicity. Journal of Drug Issues. 39(4). 893–904. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact